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In mammals, melanopsin-expressing retinal ganglion cells (mRGCs) are, among
other things, involved in several non-image-forming visual functions, including light
entrainment of circadian rhythms. Considering the profound impact of aging on visual
function and ophthalmic diseases, here we evaluate changes in mRGCs throughout
the life span in humans. In 24 post-mortem retinas from anonymous human donors
aged 10–81 years, we assessed the distribution, number and morphology of mRGCs by
immunostaining vertical retinal sections and whole-mount retinas with antibodies against
melanopsin. Human retinas showed melanopsin immunoreactivity in the cell body, axon
and dendrites of a subset of ganglion cells at all ages tested. Nearly half of the mRGCs
(51%) were located within the ganglion cell layer (GCL), and stratified in the outer (M1,
12%) or inner (M2, 16%) margin of the inner plexiform layer (IPL) or in both plexuses (M3,
23%). M1 and M2 cells conformed fairly irregular mosaics, while M3 cell distribution was
slightly more regular. The rest of the mRGCs were more regularly arranged in the inner
nuclear layer (INL) and stratified in the outer margin of the IPL (M1d, 49%). The quantity
of each cell type decrease after age 70, when the total number of mRGCs was 31%
lower than in donors aged 30–50 years. Moreover, in retinas with an age greater than
50 years, mRGCs evidenced a decrease in the dendritic area that was both progressive
and age-dependent, as well as fewer branch points and terminal neurite tips per cell
and a smaller Sholl area. After 70 years of age, the distribution profile of the mRGCs
was closer to a random pattern than was observed in younger retinas. We conclude
that advanced age is associated with a loss in density and dendritic arborization of
the mRGCs in human retinas, possibly accounting for the more frequent occurrence of
circadian rhythm disorders in elderly persons.
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INTRODUCTION
Melanopsin is an opsin protein identified in a third class of ocular
photoreceptors that are neither rods nor cones (Berson et al.,
2002; Hannibal et al., 2002; Hattar et al., 2002; Panda et al., 2002).
In mammals, it is expressed in an intrinsically photosensitive
subset of retinal ganglion cells (ipRGCs) that produce light-
induced responses without the requisite of receiving synaptic
input from other neurons in the retina (Provencio et al., 2000;
Berson et al., 2002). Melanopsin-expressing retinal ganglion
cells (mRGCs) participate in circadian and non-visual light-
induced responses, which include the photic entrainment of the
circadian system, pupillary light reflex (PLR), post-illumination
pupil response (PIPR) and masking responses to light (Panda
et al., 2002; Güler et al., 2008). The ipRGCs thus project to
a number of brain areas whose functions are not associated
with image formation, such as the suprachiasmatic nucleus
(SCN) in the case of circadian photoentrainment (Hattar et al.,
2003) and the olivary pretectal nucleus (OPN), which controls
pupillary reflex (Hattar et al., 2002, 2003). Recently, it has been
demonstrated that ipRGCs are implicated directly in cognitive
and mood functions by projecting to limbic regions, as the
lateral habenula and the medial amygdala (LeGates et al., 2012).
In primate retinas, ipRGCs are known to communicate color
and irradiance, and to project to the lateral geniculate nucleus
(LGN; Berson, 2003; Dacey et al., 2005), contributing to image-
forming processes. More recently, it has been reported that
melanopsin is also present in the human retina in the outer
segments of a cone population that do not appear to express
any other opsins. The expression of melanopsin by these cones
and their contribution to the conscious perception of light
in humans supports the idea that this particular opsin can
also act as a classical photopigment (Dkhissi-Benyahya et al.,
2006).
In rodents, five subtypes of ipRGCs have been identified
(M1–M5; Ecker et al., 2010; Esquiva et al., 2013; Reifler et al.,
2015), whereas two subtypes of monostratified ipRGCs have been
reported in both human and primates, one sending dendrites
to the outer stratum of the inner plexiform layer (IPL) and the
second stratified in the IPL inner stratum (Hannibal et al., 2004,
2014; Dacey et al., 2005; Liao et al., 2016). Labeled somas can be
found in both the inner nuclear layer (INL) and the ganglion cell
layer (GCL), respectively. More recently, it has been described in
primates that some ipRGC dendrites cross the IPL to ramify in
the opposite stratum (Liao et al., 2016).
Pupillometric measurements indicate that ipRGC function is
compromised in diseases of both the optic nerve and the retina,
including glaucoma (Feigl et al., 2011), diabetic retinopathy
(Feigl et al., 2012), retinitis pigmentosa (Kawasaki et al., 2012),
Leber’s hereditary optic neuropathy (Kawasaki et al., 2010), and
age-related macular degeneration (Maynard et al., 2015). On
the other hand, it has been described that aging affects retinal
functions, including electroretinographic responses (Jackson
et al., 2002), sensitivity to contrast (Elliott et al., 1990), visual
field sensitivity (Johnson et al., 1989; Spry and Johnson, 2001)
and adaptation to darkness (Jackson et al., 1999). Furthermore,
a large body of literature links aging to sleep alterations. These
changes may be the result of abnormal homeostatic sleep
regulation, and/or a dysfunction affecting the regulation of
circadian rhythms (Cajochen et al., 2006). Circadian rhythms
in elderly subjects have been reported to exhibit progressively
decreased amplitude, phase advancement and shorter periods
(Myers and Badia, 1995; Cajochen et al., 2006).
Multiple factors have been associated with the disturbances
in circadian timing that occur with age (Van Someren, 2000;
Karasek and Reiter, 2002). These include many degenerative
changes which have been identified in the retina and optic nerve
of aging people (Johnson et al., 1987; Gao and Hollyfield, 1992;
Curcio and Drucker, 1993; Harman et al., 2000; Eliasieh et al.,
2007). However, measurements of PIPRs have shown no effects
of aging on ipRGC inputs to the pathway controlling the pupil in
either humans (Adhikari et al., 2015) or rodless/coneless (rd/rd
cl) mice (Semo et al., 2003). Furthermore, several authors have
found data supporting the existence of a highly efficient system
for ipRGCs survival (Vugler et al., 2008; Cui et al., 2015; Nadal-
Nicolás et al., 2015), as these cells show high resistance to injury,
even in advanced stages of retinal degeneration (Esquiva et al.,
2013; Cuenca et al., 2014; García-Ayuso et al., 2015; Lax et al.,
2016).
Our objective was to establish whether aging-related circadian
disruptions in humans are associated with changes in ipRGCs.
To accomplish this, in the present study we analyze in detail
the cellular diversity of mRGCs in the human retina, and
assess possible variations in the number, morphology and
distribution of these cells in the retinas of 24 human donors, aged
10–81 years.
MATERIALS AND METHODS
Human Retinas
Twenty-four human cadaver eyes were obtained from the eye
bank of the University General Hospital of Alicante, Spain,
within 6 h of death. They did not report any personal or familial
history of retinal dystrophy. All donors signed a consent, which
includes that if the organs are not used for transplant, they can be
used for research. The human eye donors, both men and women,
ranged in age from 10 to 81 years at death, and had no past history
of ocular diseases. All subjects gave written informed consent
in accordance with the Declaration of Helsinki. This study
was carried out in accordance with the recommendations and
protocols approved by the Ethics Committee of the University
of Alicante.
Retinal Histology
The human eyeballs were fixed in paraformaldehyde (4% w/v)
for 2 h at room temperature (RT), washed in PBS and then
cryoprotected in 15%, 20% and 30% sucrose. The lens and
vitreous body were removed, and the retina was spread out
and flattened, producing four portions: the superior, inferior,
nasal and temporal. The macula was identified according to
its pigmentation and the pattern of blood vessels in the retina.
In each retina, a representative region of around 1 cm2 from
the superior-nasal area was processed for vertical sections or
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flat mount. One entire 56-year-old flat-mounted human retina
was processed and analyzed to provide a full perspective of the
number and distribution of mRGCs.
Antibodies
Immunohistochemistry techniques were performed using an
anti-melanopsin antibody (Provencio et al., 2000; rabbit
polyclonal antibody, UF028, 1:5000 dilution) raised against the
15 N-terminal amino acids of human melanopsin, which was
supplied by Dr. Ignacio Provencio (University of Virginia,
Charlottesville, VA, USA). Biotinylated goat anti-rabbit IgG
(1:100, 111-064-144; Jackson ImmunoResearch Laboratories,
West Grove, PA, USA) was used as secondary antibody for
immunoperoxidase labeling.
Immunoperoxidase Labeling
Vertical sections and retinal flat mounts were processed using
the immunoperoxidase technique, according to the procedures
already reported in previous works in great detail (Esquiva
et al., 2013). Briefly, after suppression of endogenous hydrogen
peroxide (H1009; Sigma, St. Louis, MO, USA), permeability
was enhanced by preliminary incubation in 2.28% sodium
metaperiodate (S1878; Sigma), followed by incubation in 0.02%
sodium borohydride (163314; Panreac, Barcelona, Spain). After
a blocking step, retinas were incubated in the primary antibody
for 4 days, washed and then incubated in the biotinylated
secondary antibody for 3 days. They were subsequently washed,
and incubated for two more days in avidin-biotin complex
(ABC; PK-6100, Vectastain Elite ABC Kit; Vector Laboratories
Ltd., Cambridgeshire, UK). Finally, retinas were washed and
incubated with 3,3′-diaminobenzidine tetrahydrochloride (DAB,
D5637; Sigma) containing 0.01% H2O2 and 0.025% ammonium
nickel (II) sulfate hexahydrate (A1827; Sigma). Flat retinas were
mounted with the ganglion layer side facing up, and coverslipped
for optical microscopy. Vertical sections were mounted and
coverslipped for examination under an optical microscope.
Images were obtained on a high-resolution digital microscope
(Leica DMR; Leica Microsystems) and processed using photo-
editing software (Adobe Photoshop 10.0; Adobe Systems, Inc.,
San Jose, CA, USA).
A camera lucida connected to a Leica DMRmicroscope (Leica
Microsystems) was used to trace by hand each immunostained
mRGCs in all flat-mounted retinas examined in order to
determine their type, number and spatial distribution. The
resulting images were then digitalized, using image-editing
software (Adobe Photoshop 10.0; Adobe Systems, Inc., San Jose,
CA, USA).
Morphological Analysis
Retinal flat mounts were photographed at the focal plane of
the GCL and INL. In order to recreate the soma and dendritic
profiles of the individual mRGCs, we traced by hand the shape
of the cell body, the dendritic arbor and the minimal convex
polygon that enclosed the dendritic field of several representative
mRGCs (five cells per retina of each morphological subtypes
found, 24 retinas analyzed) using a camera lucida. Measurements
were taken of the areas of each soma and dendritic profile
using ImageJ software (developed by Wayne Rasband from the
National Institutes of Health, Bethesda, MD, USA and available
at http://rsbweb.nih.gov/ij/index.html). Measurements of the cell
body cross-sectional surface area were also taken in order to
calculate the sizes of the somas, which are expressed as equivalent
diameters (the diameter of a circle of equal area).
The Bonfire program from the Firestein laboratory at Rutgers
University (Langhammer et al., 2010) was used to analyze the
morphology of mRGC neurites. From digitized neuritic arbors,
we estimated the number of branch points and terminal neurite
tips per cell. A Sholl analysis (Sholl, 1953) was also conducted by
drawing concentric circles with increasing radii around the cell
body and counting howmany times each circle crossed a neuritic
segment. The number of intersections was plotted against the
radial distance from the soma in order to obtain the Sholl profile
and the Sholl area, i.e., the area under the profile (in arbitrary
units).
The two-dimensional distribution of mRGCs was assessed
by obtaining the Delaunay segments and the Voronoi domains
associated with the mRGC mosaic using ImageJ software. The
Voronoi domain area (VDA) of a cell is the area in the retinal
plane whose points are all closer to said cell than to any
other neighboring cells in the mosaic (Galli-Resta et al., 1997).
Delaunay segments show the distance to the nearest neighbors
(NND) of each cell. VDA and NND were plotted as histograms,
fit to a Gaussian function and compared to the analysis of a
random pattern, with the same density and standard deviation
(SD; Noailles et al., 2014). Regularity index (RI) for each field
were then calculated by dividing the mean NND or VDA by
the SD (Raven et al., 2003; Reese and Keeley, 2015). There
is a direct relationship between RI and the regularity of the
mosaic; real mosaics yield nearest neighbors regularity indices
(NNRI) greater than the index derived from a theoretical random
distribution (1.91; Cook, 1996). The NND dispersion index (DI)
was obtained by calculating the ratio between the observed mean
NND and the mean distance of the nearest neighbor that can
be obtained for the ideal random dispersion (Cook, 1996; Raven
et al., 2003). The theoretical mean DI for a random distribution
is 1. The higher the DI, the less similar the distribution is to a
random pattern.
Statistical Analysis
A two-way analysis of variance (ANOVA) was used to evaluate
differences between mRGC subtypes (M1, M1d, M2 and M3)
among the donors ages (<30, 30–50, 50–70 and >70 years of
age), as well as the interactions among them, in terms of cell
number, cell distribution pattern (RI and DI) and morphological
parameters (soma diameter, dendritic area, terminal neurite tips,
branch points and Sholl area). Normal homogeneity of variance
and normal distribution were found for all analyzed categories.
In cases where a 0.05 level of significance was found, post hoc
pairwise comparisons bymeans of a Tukey’s test were conducted.
Statistical significance was considered to be p < 0.05. Data were
plotted as the mean ± SEM. A Grubb’s test was performed to
determine significant outlier values. VDA and NND data were
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fitted to a Gaussian function. Prism 6 for Windows (Graphpad
Software, Ind., La Jolla, CA, USA) was used for all statistical
analyses.
RESULTS
Melanopsin-Expressing Retinal Ganglion
Cells in Human Retinas
Single immunolabeling of human vertical retinal sections,
employing primary polyclonal antibody against human
melanopsin in conjunction with an immunoperoxidase
technique, was used to label positive ganglion cells. The
expression of melanopsin was located in the bodies, axons and
dendrites of some retinal ganglion cells. Melanopsin-positive
cell bodies appeared in the GCL and inside the INL (Figure 1A).
Dendritic processes were localized in two plexuses: one within
the outer margin of the IPL, close to the INL (stratum S1 of the
OFF sublamina), and the other on the inner side of the IPL, close
to the GCL (stratum S5 of the ON sublamina).
mRGC Types in the Human Retina
Figure 1B shows a schematic diagram of the different types
of mRGCs found in human retinas. Based on the dendritic
stratification patterns, we recognized three different subtypes of
mRGCs in the human retina: M1 cells, with arborized dendrites
in the S1 stratum of the IPL;M2 cells, stratifying in the S5 stratum
of the IPL; and M3 cells, with bistratified dendrites in both
S1 and S5 strata of the IPL. Weaker mRGC immunoreactivity
was observed in M2 cells as compared to M1 and M3 cells. The
cell bodies of M2 and M3 mRGC were located in the GCL. The
cell bodies of numerous M1 cells were found in the GCL, but the
FIGURE 1 | Melanopsin-positive ganglion cells in the human retina. (A) Representative image of a vertical section from a 53-year-old human retina labeled with
anti-melanopsin antibody. Note that melanopsin is present on the soma and neurites of cells located in the GCL and INL of the human retina. (B) Representative
drawing of the different types of melanopsin-expressing retinal ganglion cell (mRGC) found in human retina. ONL, outer nuclear layer; INL, inner nuclear layer;
IPL, inner plexiform layer; GCL, ganglion cell layer. Scale bar: 20 µm.
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cell bodies of most mRGCs stratifying in S1 were displaced to the
INL. As a result, they are understood to be displaced M1 cells
(M1d; Figures 1A,B). To our knowledge, this is the first work to
describe M3 cells in the human retina.
To analyze the stratification pattern and morphology of
mRGCs in detail, retinal flat mounts were immunostained for
melanopsin using the immunoperoxidase technique (Figure 2),
and individual cells were drawn by hand, using a camera
FIGURE 2 | mRGC types in the human retina. (A,B) Representative M1 cell with the soma and axon (arrow) located in the GCL (A) and dendrites in the stratum
S1 of the IPL (B). (C) M2 cell with the cell body located in the GCL and dendrites in S5 of the IPL. (D) Displaced M1 cell (M1d) with the body located in the INL and
dendrites in the stratum S1 of the IPL. (E,F) M3 cell with the cell body located in the GCL (E) and dendrites in both S5 (E) and S1 of the IPL (F). Scale bar: 40 µm.
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FIGURE 3 | Dendritic arborization of mRGCs in the human retina. (A–D) Examples of soma-dendritic profiles of M1, M1d, M2 and M3 cells. Dendrites in
stratum S1 and S5 are shown in blue and red, respectively, whereas axons are illustrated in black. Somas located in the GCL (M1, M2 and M3 cells) and INL (M1d
cells) are shown in red and blue, respectively. A group of smaller M2 cells was found close to the optic nerve (C, asterisk). (E) Mean soma diameter of M1, M1d,
M2 and M3 cells. A total of 400 cells were examined for each cell type. (F–I) Mean dendritic area (F), number of branch points (G), number of terminal neurite tips
per cell (H), and Sholl area (I) of each mRGC type. 40–45 cells were examined for each cell type. Different letters indicate statistical significance. Scale bar: 100 µm.
lucida (Figures 3A–D). Soma size and neurite morphology were
analyzed. In all mRGC types, soma profiles were circular in
shape (Figures 2, 3), with soma diameters significantly larger
in M2 (20.82 ± 0.19 µm) than in M1 (19.99 ± 0.26 µm)
and M1d cells (19.92 ± 0.17 µm; p < 0.05 and p < 0.01,
respectively; Figure 3E). M3 cells had somas with diameter
values (20.22 ± 0.18 µm) that fell between those observed in
M1 and M2 cells. All cell types showed branched dendritic trees
of beaded dendrites (Figures 2, 3). The mean dendritic area
of M1d cells (0.54 ± 0.02 mm2) was higher than that of M2
(0.43± 0.02 mm2) andM3 (0.44± 0.02 mm2) cells (p< 0.01 and
p < 0.05, respectively; Figure 3F). No significant differences in
the dendritic area of M1 cells (0.47 ± 0.02 mm2) were found
in any of the other cell types. The Bonfire analysis also showed
significant differences in dendritic tree morphology among the
different cell types in human retinas. With regard to the quantity
of branch points per cell (Figure 3G), both M1 (18.43 ± 0.92)
and M1d (21.57 ± 1.16) cells appeared in greater numbers than
M3 cells (14.58 ± 1.02; p < 0.05, in both cases), and M2 cells
showed lower values (17.24± 1.06; p< 0.05) than M1d cells, but
Frontiers in Aging Neuroscience | www.frontiersin.org 6 April 2017 | Volume 9 | Article 79
Esquiva et al. Human Retinal Melanopsin Cells in Aging
were not significantly different from those observed in M1 and
M3 cells. The number of terminal neurite tips per cell was also
significantly larger in M1d (24.75 ± 1.05) than in M3 cells
(18.28 ± 1.06; p < 0.001), although they did not show any
significant differences from M1 (21.44 ± 0.93) and M2 cells
(21.59 ± 1.09; Figure 3H). The Sholl area was larger in M1d
(211.1 ± 8.9) than in M2 (179.0 ± 9.3) and M3 (146.7 ± 6.5)
cells (p< 0.05 and p< 0.0001, respectively), andM1 cells showed
Sholl area values (180.7± 8.05) that were between those observed
in M1d cells and M2 cells (Figure 3I). All these results indicate
that M1d cells had a more complex dendritic arborization than
the other mRGC types, and that M3 cells had the simplest
dendritic trees among the different mRGC morphologies. Close
to the optic nerve, we found a few mRGCs with somas placed in
the GCL and small dendritic trees with short process stratifying
in the S5 stratum of the IPL. The immunoreactivity of these small
M2 cells was weaker than in the rest of M2 cells (Figure 3C,
asterisk).
mRGC Distribution and Number in Human
Retinas
In order to gain a complete perspective of the spatial distribution
and number of mRGCs in the human retina, each and every
individual mRGC from an entire flat mounted human retina
from a 56-year-old donor was morphologically characterized and
the cell body manually traced using a camera lucida. Figure 4
presents the spatial arrangement of the different types of mRGCs
in the whole-mount human retina analyzed (Figures 4A–D).
Throughout the entire retina, the total number of mRGCs was
4700, and the average cell density was 4.77 cells per mm2.
A higher density of mRGCs was observed around the fovea,
and a reduced density of mRGCs was found in the vicinity
of the optic nerve and close to the peripheral retina. The
smallest density for all mRGCs types was observed in the
superior part of the retina (Figure 4E). On the other hand, we
observed a high proportion of M1d cells throughout the entire
retina.
To obtain an average estimation of the relative density of
each mRGC-type population, each mRGC-type was counted in
a representative region of around 1 cm2 from the superior-
nasal area of 24 retinas from donors aged 10–81 years.
The mean density of M1d cells in this part of the retina
(2.05 ± 0.47 cells/mm2) was significantly greater than that of
M1 (0.51 ± 0.27 cells/mm2), M2 (0.65 ± 0.33 cells/mm2) and
M3 cells (0.97 ± 0.44 cells/mm2; p < 0.001; n = 24 in all cases).
The mean density of M1 and M2 cells was not significantly
different, and M3 cell density was significantly higher than
that measured in M1 and M2 cells (p < 0.001 and p < 0.05,
respectively; n = 24; Figure 4F).
To better characterize the two-dimensional distribution of
mRGCs, we analyzed the Voronoi domains and the Delaunay
segments of melanopsin-positive cells throughout the entire flat
mounted retina from a 56-year-old donor. Examples of the
resulting Voronoi and Delaunay tessellations, as well as the
histograms generated from these analyses, are shown in Figure 5.
The Voronoi analysis for all stained cells, independently of the
cell type, revealed that mRGCs follow a Gaussian distribution
(R2 = 0.94) in the human retina (Figure 5D, solid line). However,
the VDA histogram was similar to that described by a Voronoi
analysis of a random pattern with the same density and SD
(Figure 5D, dotted line), and Voronoi domains, showing the
regularity index (VDRI) reached a relatively low value (1.24).
In contrast, the Delaunay analysis showed that NND histograms
for all mRGCs, independently of the cell type, were well-fitted
by a Gaussian function (R2 = 0.96; Figure 5F, solid line), and
a Delaunay analysis of a random pattern could not describe
these histograms (Figure 5F, dotted line). Moreover, NNRI and
DI reached relatively high values (2.03 and 1.68, respectively),
indicating that, taken together, all mRGCs are arranged in a fairly
regular mosaic.
The Delaunay analysis for each of the mRGCs types in
the entire flat-mounted human retina showed regularity and
dispersion indices that were relatively high for M1d (2.01 and
1.70, respectively) and M3 (1.93 and 1.59, respectively) cells.
Moreover, Delaunay analyses of random patterns of the same
density and SD could not describe NND histograms for
these cell types (Figure 5G, dotted lines), indicating that
the NND are uniform, and that M1d and M3 cells are
organized into a fairly regular mosaic. In contrast, regularity
and dispersion indices for M1 (1.49 and 1.22, respectively) and
M2 (1.58 and 1.28, respectively) cells were relatively low, and
NND histograms for these cell types were well-fitted by the
Delaunay analysis of random patterns (Figure 5G), indicating
that retinal distribution ofM1 andM2 cells was close to a random
pattern.
Decrease and Degeneration of mRGCs
in the Human Retina with Aging
To assess age-dependent variations in mRGC numbers,
distribution and/or morphology, a representative region of
around 1 cm2 from the superior-nasal area of 24 flat mount
human retinas of different ages (10–81 years) was analyzed.
To calculate the relative quantities of each cell type in each
human retina, each of the cell bodies stained for melanopsin
was traced by hand, using a camera lucida (Figures 6A–D).
The mean melanopsin immunoreactive cell density showed a
decrease throughout the course of life in human retinas, with
significant differences between humans less than 70 years of age
and humans older than 70 years (p< 0.01, n = 6 in all age ranges;
Figure 6E). This age-dependent decrease in mRGCs was found
in all the cellular types of mRGCs, with significant differences in
M1d and M3 cells (Figure 6F).
To analyze age-dependent morphologic changes in mRGCs,
we manually traced the cell body and the dendritic field of
representative mRGCs from the 24 retinas analyzed (five cells
per retina of each morphological subtype described). Figure 7
presents the soma reconstruction and the full dendritic field
of individual mRGCs in a representative region of the central
superior-nasal area of representative retinas aged <30, 30–50,
50–70 and >70 years (Figures 7A–D). As shown in the figure,
there was extensive overlapping of the dendritic fields of
neighboring mRGCs, forming a dense meshwork in the IPL in
retinas younger than 30 years of age (Figure 7A). The dendritic
fields were organized in a similar manner in retinas from 30 to
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FIGURE 4 | Density and distribution of the different types of human mRGCs. (A–D) Representative drawings of a 56-year-old whole-mount human retina
(drawn by hand, using a camera lucida) showing the location of immunostained individual mRGCs of different types. The number of mRGCs shown in the drawings is
988 M1 (A), 1874 M1d (B), 802 M2 (C) and 1036 M3 (D) cells. (E) Density of the different types of mRGCs (cell/mm2) in different parts of the whole mount retina
showed in (A–D). (F) Mean density of the different types of mRGCs (cell/mm2) in the superior-nasal part of the retina of 24 human donors aged 10–81 years. Fv,
fovea; N, number of mRGCs; D, density of cells. Different letters above the histograms indicate statistical significant differences (p < 0.05). Scale bar: 5 mm.
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FIGURE 5 | Distribution pattern of human mRGCs. (A) Voronoi tessellation associated with the mRGC mosaic of a 56-year-old whole human retina.
(B) Delaunay tessellation associated with the mRGC whole retina mosaic, as well as the set of Delaunay segments for single cells, the shortest of which is the
distance of the nearest neighbor to each cell. (C) Higher magnification image of Voronoi tessellation. (D) Frequency distribution associated with the Voronoi domains,
showing the regularity index (VDRI). (E) Higher magnification image of Delaunay tessellation close to the fovea area (Fv). (F) Frequency distribution of the nearest
neighbor densities of mRGCs, independently of the cell type, showing the nearest neighbor regularity index (NNRI) and dispersion index (DI). The solid line represents
the Gaussian function fitting the data. The Voronoi (D) and Delaunay (F) analysis of a random pattern with the same density and SD is also shown for the purposes of
comparison (dotted line). (G) Frequency distribution of NND for the different types of mRGCs in the whole-mount retina showed in (A,B). N, number of cells; M,
mean value (area or distance); SD, standard deviation; R2, R-squared value. Scale bar: 5 mm.
50-year-old donors (Figure 7B). From 50 years of age onward,
it was observed that the mRGC plexus was less complex than
in younger specimens, the dendritic fields overlapped to some
degree, but with visible empty spaces in coverage (Figure 7C).
Over age 70, the mRGCs were few and far between, with barely
any contact between cells (Figure 7D). The dendritic beads
observed in all types of mRGCs (Figures 2, 3, 7E) were lost with
age. Compare representative M1 cell at 10 year old (Figure 7E)
with that at 80 year old (Figure 7F).
Themorphologic parameters quantified inmRGCs confirmed
the age-related reduction in dendritic area, number of terminal
neurite tips per cell, number of branch points, and Sholl
area in the human retinas (Figures 7G–J). More specifically,
between <30 and 30–50 years of age, we already found a
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FIGURE 6 | Number of mRGCs in the human retina with aging. (A–D) Representative drawings of the superior-nasal part of whole-mount retinas from humans
at 10 (A), 48 (B), 65 (C) and 81 (D) years of age, corresponding to the age ranges: <30, 30–50, 50–70 and >70 years. (E,F) Mean density of total mRGCs (E) and
different types of mRGCs (F) in human retinas between 10 and 81 years of age. Note the significant decrease in the number of mRGCs as of 70 years of age. Six
retinas were examined for each age range. Different letters above the histograms indicate statistical significant differences (p < 0.05). Scale bar: 1 mm.
significant decrease in terminal neurite tip numbers (p< 0.05). In
addition, from 50 years of age onward, a significant decrease was
observed in all the dendritic parameters analyzed, with regard to
measurements in <30-year-old retinas (p < 0.0001, in all cases).
From 70 years of age onwards, the value of the Bonfire dendritic
parameters analyzed were also significantly smaller than those
obtained in humans in the 50–70 year-old range (p < 0.001, in
all cases; Figures 7H–J).
Age-related changes in the mRGC distribution were assessed
by analyzing the Delaunay segments of melanopsin-positive
cells in a representative region (1 cm2, superior-nasal area)
of four flat-mounted human retinas of different ages (<30,
30–50, 50–70 and >70 years of age). Histograms showing
NND values from these analyses are presented in Figure 8.
As shown in the figure, the distribution pattern of M1 and
M2 cells grew progressively closer to a random pattern with
aging (Figures 8A,C). More concretely, the fit of NND values in
M1 and M2 cells to a Gaussian function (Figure 8, solid lines)
grew progressively closer to the NND values of random patterns
having an identical density and SD (Figure 8, dotted lines), and
regularity and dispersion indices were progressively lower with
aging. These cell types were arranged in a fairly regular mosaic at
young ages (RI around 1.91), but with age they showed a more
random distribution. Nevertheless, M3 cells were arranged in a
fairly regular mosaic (NNRI) approximating the theoretical limit
of 1.91 for a random population (Cook, 1996) in most of the
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FIGURE 7 | mRGC morphological and arborization changes in human retinas with aging. (A–D) Representative drawings of the soma and complete
dendritic field of mRGCs from the central superior-nasal retinal region of human retinas at 10 (A), 46 (B), 53 (C) and 89 (D) years of age, corresponding to the age
ranges: <30, 30–50, 50–70 and >70 years. (E,F) Examples of dendritic profiles of M1 cells from human retinas at 10 (E) and 81 (F) years of age. Dendrites, in
stratum S1, are shown in blue. Somas, located in the GCL, are shown in red. Axon is illustrated in black. (G–J) Average dendritic area (G), number of branch points
(H), number of terminal neurite tips per cell (I), and Sholl area (J) of the different types of mRGCs in human retinas with ages belonging to the ranges: <30, 30–50,
50–70 and >70 years. 12–17 cells from nine retinas were examined per age range. Different letters above the histograms indicate statistical significant differences
(p < 0.05). Scale bar: 100 µm.
examined ages (Figure 8D). M1d cells were arranged in a regular
mosaic (NNRI> 1.91) in all of the ages examined (Figure 8B).
DISCUSSION
The present study shows that human retinas contain a minimum
of three melanopsin-positive retinal ganglion cells subtypes (M1,
M2 and M3), distributed throughout the entire retina in cell
mosaics. These are more or less regular, depending on the
cell subtype. Here we also demonstrate that mRGC density
significantly decreases in people over 70 years of age, even though
a progressive decline is observed from age 50, accompanied by a
reduction in dendritic arborization in association with age. Over
the course of a lifetime, the distribution profile of mRGCs grows
progressively closer to a random pattern.
Over the entire human retina, immunolabeling with
melanopsin antibodies revealed a morphologically distinct
population of 4700 cells (4.77 cells/mm2), which correspond
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FIGURE 8 | Distribution pattern of mRGCs in human retinas with aging. (A–D) Frequency distribution of the nearest neighbor densities of M1 (A), M1d (B), M2
(C) and M3 (D) cells in four representative human retinas at 10, 48, 65 and 81 years of age, corresponding to the age ranges: <30, 30–50, 50–70 and >70 years.
The solid line in each histogram represents the Gaussian function fitting the data. The dotted line corresponds to the Voronoi analysis of a random pattern with the
same density and SD. D, mean density; M, mean distance; SD, standard deviation; NNRI, nearest neighbor regularity index; DI, dispersion index; R2, R-squared
value.
to 0.4% of the entire population of ganglion cells in the retina
(assuming that the human retina has a total of 1.07 million
RGCs; Curcio and Allen, 1990). This value is comparable to
those reported by Liao et al. (2016). In other previous studies,
however, the reported density of human mRGCs was between
≈0.8% (Hannibal et al., 2004) and 1.5% (La Morgia et al., 2010)
of the total number of ganglion cells. These differences could be
due to the fact that, in these studies, the analyses were conducted
in randomly selected areas (not throughout the entire retina),
to differences in the labeling methods, or both. An increased
density of mRGCs was found in the temporal part of the retina,
close to the parafoveal retina, which is in accordance with
previously reported data (Dacey et al., 2005; La Morgia et al.,
2010; Liao et al., 2016). Furthermore, in the far periphery, we
found a greater concentration of mRGCs within the nasal retina.
In agreement with this result, a peak in the quantity of mRGCs
on the edge of the nasal hemiretina has been previously reported
(La Morgia et al., 2010). The distribution patterns of mRGCs
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previously reported for non-human species (Hattar et al., 2002;
Semo et al., 2005; Esquiva et al., 2013) are different from those
found in humans.
Distribution and Types of mRGCs
in Human Retinas
Two morphologically distinct melanopsin-positive cells have
been previously reported in three species of primates, namely
marmosets (Jusuf et al., 2007), macaques and humans (Hannibal
et al., 2004; Dacey et al., 2005). In one case, the dendrites were
monostratified in the outermost stratum of the IPL, whereas
the dendrites of the second type were located mainly in the
innermost stratum. This anatomical description of primate
melanopsin cells, which are similar to rodent M1 and M2 cells,
was later confirmed (Dkhissi-Benyahya et al., 2006; La Morgia
et al., 2010; Neumann et al., 2011) and the cells have been referred
to accordingly (Neumann et al., 2011).
Immunoperoxidase studies enabled us to clearly classify
human mRGCs into three different cell subtypes: M1, M2 and
M3. M1 cells, with dendrites stratifying exclusively in the outer
IPL, constituted 12% of the total mRGCs. Cells with the same
characteristics were previously found in primates (Dacey et al.,
2005; Jusuf et al., 2007). A population of mRGCs stratifying
in the IPL’s outer stratum had their soma displaced in the
INL, and thus were considered as displaced M1 cells. Other
researchers have previously described mRGCs with the same
morphology in the retina of rats (Engelund et al., 2010; Esquiva
et al., 2013, 2016), mice (Schmidt and Kofuji, 2009; Berson
et al., 2010) and humans (Hannibal et al., 2004; Dacey et al.,
2005; La Morgia et al., 2010). As occurs in the rat, M1d cells
present a great similarity to M1 cells with regard to dendritic
area, morphology and distribution of its dendrites, and for
that reason we consider them to fall within the M1 group.
Jusuf et al. (2007) reached this same conclusion when they
found that some cells stratifying into the outer layer of the
IPL could have their soma displaced to the INL in the retina
of the common marmoset (Jusuf et al., 2007). M1d cells were
the predominant cell subtype in the human retinas (49%),
corroborating previous studies in primates (Hannibal et al., 2004;
Dacey et al., 2005; Jusuf et al., 2007). The proportion of M1 and
M1d represented about 60% of the total mRGCs, which is in
accordance with what has been previously reported by Dacey
et al. (2005) for outer-stratifying cells in the retinas of macaques
and humans.
The dendrites of the second cell type we found, M2, project
only to the inner melanopsin-immunoreactive plexus, remaining
close to the GCL, in the stratum S5 of the IPL. These cells
probably correspond to previously documented mono-stratified
melanopsin cells in human and non-human primates (Dacey
et al., 2005; Jusuf et al., 2007), whose dendrites project to the
innermost IPL layer (S5). The proportion of these cells was
similar to the proportion of M1 cells (16%). In addition, close
to the optic nerve, a group of M2 cells was found with small
dendritic trees. Small mRGCs has been previously described in
macaques (Liao et al., 2016).
We found a third mRGCs cell type, M3, which had not
been previously described in humans and whose dendrites
projected in both strata of the IPL. In most cases, the dendrites
of these bistratified cells were divided almost evenly between
each stratum, but there were also cells with a majority of
their dendrites in the outer stratum and cells whose dendrites
were mostly located in the inner stratum. In marmoset (Jusuf
et al., 2007), human and macaque (Liao et al., 2016) retinas,
both M1 and M2 cells projecting some of their processes
into the ‘‘wrong’’ plexus have been occasionally seen, but no
bistratified cells had been reported so far in humans. Bistratified
or M3 mRGCs with dendrites projecting in both IPL strata
have been previously reported in mice and rats (Viney et al.,
2007; Schmidt et al., 2008; Berson et al., 2010; Esquiva et al.,
2013). Some authors argued that bistratified mRGCs in mice
cannot be considered a distinct cell type because they do
not form a distinct mosaic that uniformly tiles the retina
(Berson et al., 2010). However, we found M3 cells regularly
distributed throughout the entire human retina. Nevertheless,
it will be necessary to conduct electrophysiological experiments
to ascertain whether human melanopsin bistratified cells have
characteristic physiological properties that are similar to those
reported for M3 cells in mice (Schmidt and Kofuji, 2011).
In rodents, the number of bistratified mRGCs was fewer
(approximately 10%; Berson et al., 2010; Esquiva et al., 2013)
as compared to what we found in human retinas (23%). In
the present study we identified, for the first time, a bistratified
subtype of mRGCs in human retinas, showing that the human
retina contains at least three different subtypes of mRGCs
(M1–M3). The dendrites of all these types of mRGCs form a
dense meshwork, as previously described (Provencio et al., 2002;
Jusuf et al., 2007).
Regarding the staining intensity of these cell types, M2 cell
immunoreactivity was weaker than that of M1 and M3 human
cells, which agrees with previous studies on mice (Berson et al.,
2010) and rats (Esquiva et al., 2013). In humans, there are
two isoforms of Opn4 (Jagannath et al., 2015). Thus, the low
immunoreactivity of M2 cells may be due to the fact that,
contrary to what occurs in other cell types, only one of the
isoforms is expressed in these cells, as previously described in
mice (Pires et al., 2010). Another possibility is that both isoforms
are expressed in all three cell subtypes, but the concentration
of the protein is substantially lower in M2 than in M1 and
M3 cells.
Having several different types of mRGCs appears to be a
common feature among mammals. In mouse (Ecker et al., 2010)
and rat (Reifler et al., 2015) retinas, two other subtypes of
ipRGCs (M4 and M5) have been described. However, M5 cells
are melanopsin immunonegative in both animal species, and
M4 cells show melanopsin immunostaining in mice only after
strong amplification of the immunofluorescence (Estevez et al.,
2012) and they lack any obvious staining in rat retinas (Esquiva
et al., 2013; Reifler et al., 2015). These results suggest that the
lowest expression levels among ipRGCs are found in M4 and
M5 cells, with levels below the detection threshold either because
of the staining method or the presence of a photopigment other
than melanopsin. Thus, it is entirely possible that human retinas
have more types of ipRGCs than were found in our study.
Once again, electrophysiological studies would be needed to
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determine whether M4 and M5 cell types exist in the retina of
humans.
In our results, the distribution of M1d and M3 cells form
fairly regular cellular mosaics. Conversely, M1 and M2 cells
are arranged in more irregular mosaics within the GCL. It
may be that M1 and M2 cells are not arranged according to a
regular distribution due to their low density. Raven et al. (2003)
have found that low-density cell mosaics can resemble random
distributions. Retinal cells that share a common function are
usually regularly distributed. However, it has been reported that
in cat retinas, mRGCs have a randomdistribution throughout the
GCL (Semo et al., 2005).
Age-Dependent Changes in Density,
Distribution and Morphology of Human
mRGCs
Previous studies in humans showed that between 31 and 60 years
of age, the axon population of retinal ganglion cells progressively
decreases (Johnson et al., 1987). Since then, different researchers
have found that the number of RGC in the GCL decreases
with age (Gao and Hollyfield, 1992; Curcio and Drucker, 1993;
Harman et al., 2000). The loss of RGC reported for the entire
human retina is 0.5% per year, with a total loss of 38% over
the course of a lifetime (Harman et al., 2000). On the other
hand, evidences suggest a progressive increase in the retinal
area in humans until approximately 30 years of age, remaining
relatively constant for the rest of the life (Harman et al., 1997).
Furthermore, resistance of mRGCs to cell injury has been
reported in different animal models (Robinson and Madison,
2004; Li et al., 2006, 2008). In humans, it has also been shown that
mRGCs resist neurodegeneration as the result of mitochondrial
dysfunction, corroborating the robustness and resistance of these
cells (La Morgia et al., 2010).
In this work, we show that human mRGC density is
not strongly affected until advanced ages, with no significant
differences being found until 70 years of age. From 50 years of age
onward, we observed a tendency to decrease, which amounted
to just about 13%, a lower value than that reported for total
RGCs (about 30%; Harman et al., 2000). However, a marked drop
in mRGCs was seen after age 70, with a significant decrease of
approximately 44% in the total number of mRGCs (as compared
to the youngest retinas). Since the size of the retina remains
relatively constant from the age of 30 in humans (Harman et al.,
1997), this fall in the mRGC density from 70 years old is not
attributable to changes in the retinal size. On the other hand,
dendritic parameters indicated a progressive atrophy of mRGC
dendritic trees with aging. The atrophy of the dendritic trees start
before mRGCs number decreasing. After 50 years of age, mRGC
plexuses were significantly less complex, and from 70 years of age
onward, mRGCs showed little synaptic contacts and overlapping
of dendritic fields between the scarce number of remaining cells.
Moreover, after 70 years of age, the distribution profile ofmRGCs
was closer to a random pattern than that observed in younger
retinas.
All these results are in concordance with previous studies
showing age-related decreases of mRGCs in animal models
(Semo et al., 2003; Esquiva et al., 2013; Lax et al., 2016).
Furthermore, La Morgia et al. (2010) compared post-mortem
retinal specimens from two donors in their mid-fifties and
another over 80 years of age, and found that mRGCs are
lost with age. In humans, the presence of lipofuscin deposits
have also been reported in melanopsin cells, something
that could potentially have a progressive impact on their
functionality with age (Vugler et al., 2007). The progressive
age-dependent loss of mRGCs can explain the fact that
in older retinas, the distribution profile of mRGCs was
closer to a random pattern than in younger retinas. In
this sense, it has been reported that cell mosaics with
low densities can resemble random distributions (Raven
et al., 2003). The advanced age at which we found a
significant decrease in mRGC density agrees with previous
studies revealing the resistance of mRGCs to cell injury
(Robinson and Madison, 2004; Li et al., 2006, 2008; La
Morgia et al., 2010). Moreover, the recently described lack
of effect of age on M1 cell inputs to the human pupil
control pathway prior to 70 years of age (Adhikari et al.,
2015) is also in concordance with our results, which reveal
no significant differences in the number of M1 cells before
this age.
Age-related numerical and morphological changes in human
mRGCs occurred in all cell types. This fact is interesting
because different types of melanopsin-expressing cells project
to different areas of the brain, and are therefore involved
in different functions, including the photosynchronization of
the biological clock, sleep regulation, pupillary constriction,
cognition etc. Although we only found statistically significant
differences in M1d and M3 cells, the other two mRGC types
showed a progressive and more regular decline. Because we
don’t have data about the specific function of M1d, M2 and
M3 melanopsin cell types, it is difficult to assign which cell
type is involved in the impairment of the circadian rhythms
in humans. Thus, the loss of all types of melanopsin cells
can affect all the functions in which these photoreceptors are
involved. The marked decline in mRGC density after 70 years
of age in human retinas may therefore be the cause of the
circadian rhythm desynchronization observed in elderly humans
(Myers and Badia, 1995; Tales et al., 2001; Cajochen et al., 2006;
Schmidt et al., 2012). Other alterations of the circadian cycles
also occur with age, such as the gradual decrease in nocturnal
melatonin secretion (Karasek and Reiter, 2002) and alterations
in the sleep/wake phases (Neikrug and Ancoli-Israel, 2010), the
functioning of which involves ipRGCs. All these alterations have
been considered within the wide variety of pathologies associated
with age (Gibson et al., 2008). It has recently been shown
that variations in the melanopsin phototransduction circuitry
can partially account for individual differences in sleep timing
(van der Meijden et al., 2016). In glaucoma, that course with
ganglion cell death, a loss of circadian rhythms and impairment
of pupillary constriction have been reported (Feigl et al., 2011;
Kankipati et al., 2011; Nissen et al., 2014; Obara et al., 2016) that
could be related to the loss of mRGCs. Also, the PLR is reported
to be reduced in amplitude in Alzheimer’s disease (Tales et al.,
2001; La Morgia et al., 2016) that could be correlated with the
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loss of mRGCs in this disease and circadian dysfunction (Feng
et al., 2016).
Circadian rhythms and other functions in which mRGCs
are involved can be affected by both the atrophy of the
dendritic trees and the loss of mRGCs. In our results the
dendritic impairment reduces the number of synaptic contacts
between mRGCs, which may contribute to circadian rhythm
desynchronization. On the other hand, the age-related reduction
in dendritic arborization could result in decreased amounts
of available photopigment and, therefore, in reduced light
sensitivity. In advanced stages of retinal degeneration, previous
studies in rats provide evidences that the progressive loss in
both density and dendritic arborization of mRGCs correlates
with the occurrence of circadian dysfunctions (Lax et al.,
2016).
We can conclude that advanced age is associated with
a progressive loss in the density and dendritic arborization
of the three subtypes of mRGCs found in human retinas,
possibly accounting for the more frequent occurrence of
circadian rhythm disorders in elderly persons, including sleep
disturbances and cognitive alterations, such as learning, memory
and mood. All this changes can be a consequence of the
normal process of aging/senescence of the retina as well as
other brain areas. Preservation of human retinal degenerations
can prevent circadian disorders in older humans. Therefore,
these results highlight the importance of protecting and taking
care of the retina, and melanopsin cells, throughout the entire
lifetime.
AUTHOR CONTRIBUTIONS
NC was in charge of the experimental design. GE conducted
the experiments, acquired and analyzed the data and drafted
the manuscript. PL helped analyze the data and revise the
manuscript. GE, PL, JMG-F, JJP-S and NC discussed the results
and manuscript.
FUNDING
This research was supported by grants from the Spanish
Ministry of Economy and Competitiveness (MINECO-
FEDER BFU2015-67139-R), Instituto de Salud Carlos III
(RETICS-FEDER RD16/0008/0016) and Generalitat Valenciana
(PROMETEO/2016/158).
ACKNOWLEDGMENTS
The authors wish to thank Dr. Ignacio Provencio for providing
the anti-human melanopsin antibody.
REFERENCES
Adhikari, P., Pearson, C. A., Anderson, A. M., Zele, A. J., and Feigl, B.
(2015). Effect of age and refractive error on the melanopsin mediated
post-illumination pupil response (PIPR). Sci. Rep. 5:17610. doi: 10.1038/srep
17610
Berson, D. M. (2003). Strange vision: ganglion cells as circadian
photoreceptors. Trends Neurosci. 26, 314–320. doi: 10.1016/S0166-2236(03)
00130-9
Berson, D.M., Castrucci, A.M., and Provencio, I. (2010).Morphology andmosaics
of melanopsin-expressing retinal ganglion cell types in mice. J. Comp. Neurol.
518, 2405–2422. doi: 10.1002/cne.22381
Berson, D. M., Dunn, F. A., and Takao, M. (2002). Phototransduction by
retinal ganglion cells that set the circadian clock. Science 295, 1070–1073.
doi: 10.1126/science.1067262
Cajochen, C., Münch, M., Knoblauch, V., Blatter, K., and Wirz-Justice, A. (2006).
Age-related changes in the circadian and homeostatic regulation of human
sleep. Chronobiol. Int. 23, 461–474. doi: 10.1080/07420520500545813
Cook, J. E. (1996). Spatial properties of retinal mosaics: an empirical
evaluation of some existing measures. Vis. Neurosci. 13, 15–30.
doi: 10.1017/s0952523800007094
Cuenca, N., Fernández-Sánchez, L., Campello, L., Maneu, V., De la Villa, P.,
Lax, P., et al. (2014). Cellular responses following retinal injuries and
therapeutic approaches for neurodegenerative diseases. Prog. Retin. Eye Res. 43,
17–75. doi: 10.1016/j.preteyeres.2014.07.001
Cui, Q., Ren, C., Sollars, P. J., Pickard, G. E., and So, K.-F. (2015). The injury
resistant ability of melanopsin-expressing intrinsically photosensitive retinal
ganglion cells. Neuroscience 284, 845–853. doi: 10.1016/j.neuroscience.2014.
11.002
Curcio, C. A., and Allen, K. A. (1990). Topography of ganglion cells in human
retina. J. Comp. Neurol. 300, 5–25. doi: 10.1002/cne.903000103
Curcio, C. A., and Drucker, D. N. (1993). Retinal ganglion cells in Alzheimer’s
disease and aging. Ann. Neurol. 33, 248–257. doi: 10.1002/ana.4103
30305
Dacey, D. M., Liao, H.-W., Peterson, B. B., Robinson, F. R., Smith, V. C.,
Pokorny, J., et al. (2005). Melanopsin-expressing ganglion cells in primate
retina signal colour and irradiance and project to the LGN. Nature 433,
749–754. doi: 10.1038/nature03387
Dkhissi-Benyahya, O., Rieux, C., Hut, R. A., and Cooper, H. M. (2006).
Immunohistochemical evidence of a melanopsin cone in human retina. Invest.
Ophthalmol. Vis. Sci. 47, 1636–1641. doi: 10.1167/iovs.05-1459
Ecker, J. L., Dumitrescu, O. N.,Wong, K. Y., Alam, N.M., Legates, T., Renna, J. M.,
et al. (2010). Melanopsin-expressing retinal ganglion-cell photoreceptors:
cellular diversity and role in pattern vision. Neuron 67, 49–60. doi: 10.1016/
j.neuron.2010.05.023
Eliasieh, K., Liets, L. C., and Chalupa, L. M. (2007). Cellular reorganization in the
human retina during normal aging. Invest. Ophthalmol. Vis. Sci. 48, 2824–2830.
doi: 10.1167/iovs.06-1228
Elliott, D., Whitaker, D., and MacVeigh, D. (1990). Neural contribution to
spatiotemporal contrast sensitivity decline in healthy ageing eyes. Vision Res.
30, 541–547. doi: 10.1016/0042-6989(90)90066-t
Engelund, A., Fahrenkrug, J., Harrison, A., and Hannibal, J. (2010). Vesicular
glutamate transporter 2 (VGLUT2) is co-stored with PACAP in projections
from the rat melanopsin-containing retinal ganglion cells. Cell Tissue Res. 340,
243–255. doi: 10.1007/s00441-010-0950-3
Esquiva, G., Avivi, A., and Hannibal, J. (2016). Non-image forming light
detection by melanopsin, rhodopsin and long-middlewave (L/W) cone opsin
in the subterranean blind mole rat, spalax ehrenbergi: immunohistochemical
characterization, distribution and connectivity. Front. Neuroanat. 10:61.
doi: 10.3389/fnana.2016.00061
Esquiva, G., Lax, P., and Cuenca, N. (2013). Impairment of intrinsically
photosensitive retinal ganglion cells associated with late stages of retinal
degeneration. Invest. Ophthalmol. Vis. Sci. 54, 4605–4618. doi: 10.1167/iovs.13-
12120
Estevez, M. E., Fogerson, P. M., Ilardi, M. C., Borghuis, B. G., Chan, E.,
Weng, S., et al. (2012). Form and function of the M4 cell, an intrinsically
photosensitive retinal ganglion cell type contributing to geniculocortical
vision. J. Neurosci. 32, 13608–13620. doi: 10.1523/JNEUROSCI.1422-
12.2012
Feigl, B., Mattes, D., Thomas, R., and Zele, A. J. (2011). Intrinsically photosensitive
(melanopsin) retinal ganglion cell function in glaucoma. Invest. Ophthalmol.
Vis. Sci. 52, 4362–4367. doi: 10.1167/iovs.10-7069
Frontiers in Aging Neuroscience | www.frontiersin.org 15 April 2017 | Volume 9 | Article 79
Esquiva et al. Human Retinal Melanopsin Cells in Aging
Feigl, B., Zele, A. J., Fader, S. M., Howes, A. N., Hughes, C. E., Jones, K. A.,
et al. (2012). The post-illumination pupil response of melanopsin-expressing
intrinsically photosensitive retinal ganglion cells in diabetes. Acta Ophthalmol.
90, e230–e234. doi: 10.1111/j.1755-3768.2011.02226.x
Feng, R., Li, L., Yu, H., Liu, M., and Zhao, W. (2016). Melanopsin retinal ganglion
cell loss and circadian dysfunction in Alzheimer’s disease (Review).Mol. Med.
Rep. 13, 3397–4000. doi: 10.3892/mmr.2016.4966
Galli-Resta, L., Resta, G., Tan, S. S., and Reese, B. E. (1997). Mosaics of islet-
1-expressing amacrine cells assembled by short-range cellular interactions.
J. Neurosci. 17, 7831–7838.
Gao, H., and Hollyfield, J. G. (1992). Aging of the human retina. Differential loss
of neurons and retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 33,
1–17.
García-Ayuso, D., Di Pierdomenico, J., Esquiva, G., Nadal-Nicolás, F. M.,
Pinilla, I., Cuenca, N., et al. (2015). Inherited photoreceptor degeneration
causes the death of melanopsin-positive retinal ganglion cells and increases
their coexpression of Brn3a. Invest. Ophthalmol. Vis. Sci. 56, 4592–4604.
doi: 10.1167/iovs.15-16808
Gibson, E. M., Williams, W. P., and Kriegsfeld, L. J. (2008). Aging in the
circadian system: considerations for health, disease prevention and longevity.
Exp. Gerontol. 44, 51–56. doi: 10.1016/j.exger.2008.05.007
Güler, A. D., Ecker, J. L., Lall, G. S., Haq, S., Altimus, C. M., Liao, H.-W.,
et al. (2008). Melanopsin cells are the principal conduits for rod-cone
input to non-image-forming vision. Nature 453, 102–105. doi: 10.1038/nature
06829
Hannibal, J., Hindersson, P., Knudsen, S. M., Georg, B., and Fahrenkrug, J.
(2002). The photopigment melanopsin is exclusively present in pituitary
adenylate cyclase-activating polypeptide-containing retinal ganglion cells of the
retinohypothalamic tract. J. Neurosci. 22:RC191.
Hannibal, J., Hindersson, P., Ostergaard, J., Georg, B., Heegaard, S., Larsen, P. J.,
et al. (2004). Melanopsin is expressed in PACAP-containing retinal ganglion
cells of the human retinohypothalamic tract. Invest. Ophthalmol. Vis. Sci. 45,
4202–4209. doi: 10.1167/iovs.04-0313
Hannibal, J., Kankipati, L., Strang, C. E., Peterson, B. B., Dacey, D., and
Gamlin, P. D. (2014). Central projections of intrinsically photosensitive retinal
ganglion cells in the macaque monkey. J. Comp. Neurol. 522, 2231–2248.
doi: 10.1002/cne.23588
Harman, A., Abrahams, B., Moore, S., and Hoskins, R. (2000). Neuronal density
in the human retinal ganglion cell layer from 16–77 years. Anat. Rec.
260, 124–131. doi: 10.1002/1097-0185(20001001)260:2<124::AID-AR20 >3.3.
CO;2-4
Harman, A. M., Fleming, P. A., Hoskins, R. V., and Moore, S. R. (1997).
Development and aging of cell topography in the human retinal pigment
epithelium. Invest. Ophthalmol. Vis. Sci. 38, 2016–2026.
Hattar, S., Liao, H. W., Takao, M., Berson, D. M., and Yau, K. W. (2002).
Melanopsin-containing retinal ganglion cells: architecture, projections and
intrinsic photosensitivity. Science 295, 1065–1070. doi: 10.1126/science.
1069609
Hattar, S., Lucas, R. J., Mrosovsky, N., Thompson, S., Douglas, R. H.,
Hankins, M. W., et al. (2003). Melanopsin and rod-cone photoreceptive
systems account for all major accessory visual functions in mice. Nature 424,
76–81. doi: 10.1038/nature01761
Jackson, G. R., Ortega, J., Girkin, C., Rosenstiel, C. E., and Owsley, C. (2002).
Aging-related changes in the multifocal electroretinogram. J. Opt. Soc. Am. A
Opt. Image Sci. Vis. 19, 185–189. doi: 10.1364/josaa.19.000185
Jackson, G. R., Owsley, C., and McGwin, G. Jr. (1999). Aging and dark adaptation.
Vision Res. 39, 3975–3982. doi: 10.1016/s0042-6989(99)00092-9
Jagannath, A., Hughes, S., Abdelgany, A., Pothecary, C. A., Di Pretoro, S.,
Pires, S. S., et al. (2015). Isoforms of melanopsin mediate different behavioral
responses to light. Curr. Biol. 25, 2430–2434. doi: 10.1016/j.cub.2015.
07.071
Johnson, C. A., Adams, A. J., and Lewis, R. A. (1989). Evidence for a neural basis
of age-related visual field loss in normal observers. Invest. Ophthalmol. Vis. Sci.
30, 2056–2064.
Johnson, B. M., Miao, M., and Sadun, A. A. (1987). Age-related decline
of human optic nerve axon populations. Arch. Ophthalmol. 10, 5–9.
doi: 10.1007/bf02431765
Jusuf, P. R., Lee, S. C. S., Hannibal, J., and Grünert, U. (2007). Characterization
and synaptic connectivity of melanopsin-containing ganglion cells in the
primate retina. Eur. J. Neurosci. 26, 2906–2921. doi: 10.1111/j.1460-9568.2007.
05924.x
Kankipati, L., Girkin, C. A., and Gamlin, P. D. (2011). The post-illumination
pupil response is reduced in glaucoma patients. Invest. Ophthalmol. Vis. Sci.
52, 2287–2292. doi: 10.1167/iovs.10-6023
Karasek, M., and Reiter, R. J. (2002). Melatonin and aging. Neuro Endocrinol. Lett.
23, 14–16.
Kawasaki, A., Crippa, S. V., Kardon, R., Leon, L., and Hamel, C. (2012).
Characterization of pupil responses to blue and red light stimuli in autosomal
dominant retinitis pigmentosa due to NR2E3 mutation. Invest. Ophthalmol.
Vis. Sci. 53, 5562–5569. doi: 10.1167/iovs.12-10230
Kawasaki, A., Herbst, K., Sander, B., and Milea, D. (2010). Selective wavelength
pupillometry in Leber hereditary optic neuropathy. Clin. Exp. Ophthalmol. 38,
322–324. doi: 10.1111/j.1442-9071.2010.02212.x
La Morgia, C., Ross-Cisneros, F. N., Koronyo, Y., Hannibal, J., Gallassi, R.,
Cantalupo, G., et al. (2016). Melanopsin retinal ganglion cell loss in Alzheimer
disease. Ann. Neurol. 79, 90–109. doi: 10.1002/ana.24548
La Morgia, C., Ross-Cisneros, F. N., Sadun, A. A., Hannibal, J., Munarini, A.,
Mantovani, V., et al. (2010). Melanopsin retinal ganglion cells are resistant to
neurodegeneration inmitochondrial optic neuropathies. Brain 133, 2426–2438.
doi: 10.1093/brain/awq155
Langhammer, C. G., Previtera, M. L., Sweet, E. S., Sran, S. S., Chen, M.,
and Firestein, B. L. (2010). Automated Sholl analysis of digitized neuronal
morphology at multiple scales: whole cell Sholl analysis versus Sholl analysis
of arbor subregions. Cytometry A 77, 1160–1168. doi: 10.1002/cyto.a.20954
Lax, P., Esquiva, G., Fuentes-Broto, L., Segura, F., Sánchez-Cano, A., Cuenca, N.,
et al. (2016). Age-related changes in photosensitive melanopsin-expressing
retinal ganglion cells correlate with circadian rhythm impairments in sighted
and blind rats. Chronobiol. Int. 33, 374–391. doi: 10.3109/07420528.2016.
1151025
LeGates, T. A., Altimus, C. M., Wang, H., Lee, H.-K., Yang, S., Zhao, H.,
et al. (2012). Aberrant light directly impairs mood and learning through
melanopsin-expressing neurons. Nature 491, 594–598. doi: 10.1038/
nature11673
Li, R. S., Chen, B.-Y., Tay, D. K., Chan, H. H. L., Pu, M.-L., and So, K.-F. (2006).
Melanopsin-expressing retinal ganglion cells are more injury-resistant in a
chronic ocular hypertensionmodel. Invest. Ophthalmol. Vis. Sci. 47, 2951–2958.
doi: 10.1167/iovs.05-1295
Li, S.-Y., Yau, S.-Y., Chen, B.-Y., Tay, D. K., Lee, V. W. H., Pu, M.-L., et al. (2008).
Enhanced survival of melanopsin-expressing retinal ganglion cells after injury
is associated with the PI3 K/Akt pathway. Cell. Mol. Neurobiol. 28, 1095–1107.
doi: 10.1007/s10571-008-9286-x
Liao, H.-W., Ren, X., Peterson, B. B., Marshak, D. W., Yau, K.-W., Gamlin, P. D.,
et al. (2016). Melanopsin-expressing ganglion cells in macaque and human
retinas form two morphologically distinct populations. J. Comp. Neurol. 524,
2845–2872. doi: 10.1002/cne.23995
Maynard, M. L., Zele, A. J., and Feigl, B. (2015). Melanopsin-mediated
post-illumination pupil response in early age-related macular degeneration.
Invest. Ophthalmol. Vis. Sci. 56, 6906–6913. doi: 10.1167/iovs.15-17357
Myers, B. L., and Badia, P. (1995). Changes in circadian rhythms and sleep
quality with aging: mechanisms and interventions. Neurosci. Biobehav. Rev. 19,
553–571. doi: 10.1016/0149-7634(95)00018-6
Nadal-Nicolás, F. M., Sobrado-Calvo, P., Jiménez-López, M., Vidal-Sanz, M.,
and Agudo-Barriuso, M. (2015). Long-term effect of optic nerve axotomy on
the retinal ganglion cell layer. Invest. Ophthalmol. Vis. Sci. 56, 6095–6112.
doi: 10.1167/iovs.15-17195
Neikrug, A. B., and Ancoli-Israel, S. (2010). Sleep disorders in the older adult—a
mini-review. Gerontology 56, 181–189. doi: 10.1159/000236900
Neumann, S., Haverkamp, S., and Auferkorte, O. N. (2011). Intrinsically
photosensitive ganglion cells of the primate retina express distinct
combinations of inhibitory neurotransmitter receptors. Neuroscience 199,
24–31. doi: 10.1016/j.neuroscience.2011.10.027
Nissen, C., Sander, B., Milea, D., Kolko, M., Herbst, K., Hamard, P., et al. (2014).
Monochromatic pupillometry in unilateral glaucoma discloses no adaptive
changes subserved by the ipRGCs. Front. Neurol. 5:15. doi: 10.3389/fneur.2014.
00015
Noailles, A., Fernández-Sánchez, L., Lax, P., and Cuenca, N. (2014). Microglia
activation in a model of retinal degeneration and TUDCA neuroprotective
effects. J. Neuroinflammation 11:186. doi: 10.1186/s12974-014-0186-3
Frontiers in Aging Neuroscience | www.frontiersin.org 16 April 2017 | Volume 9 | Article 79
Esquiva et al. Human Retinal Melanopsin Cells in Aging
Obara, E. A., Hannibal, J., Heegaard, S., and Fahrenkrug, J. (2016). Loss of
melanopsin-expressing retinal ganglion cells in severely staged glaucoma
patients. Invest. Opthalmol. Vis. Sci. 57, 4661–4667. doi: 10.1167/iovs.16-
19997
Panda, S., Sato, T. K., Castrucci, A. M., Rollag, M. D., DeGrip, W. J.,
Hogenesch, J. B., et al. (2002). Melanopsin (Opn4) requirement for
normal light-induced circadian phase shifting. Science 298, 2213–2216.
doi: 10.1126/science.1076848
Pires, S. S., Hughes, S., Turton, M., Melyan, Z., Peirson, S. N., Zheng, L.,
et al. (2010). Differential expression of two distinct functional isoforms of
melanopsin (Opn4) in the mammalian retina. J. Neurosci. 29, 12332–12342.
doi: 10.1523/JNEUROSCI.2036-09.2009
Provencio, I., Rodriguez, I. R., Jiang, G., Hayes, W. P., Moreira, E. F., and
Rollag, M. D. (2000). A novel human opsin in the inner retina. J. Neurosci. 20,
600–605.
Provencio, I., Rollag, M. D., and Castrucci, A. M. (2002). Photoreceptive net in the
mammalian retina. This mesh of cells may explain how some blind mice can
still tell day from night. Nature 415:493. doi: 10.1038/415493a
Raven, M. A., Eglen, S. J., Ohab, J. J., and Reese, B. E. (2003). Determinants of the
exclusion zone in dopaminergic amacrine cell mosaics. J. Comp. Neurol. 461,
123–136. doi: 10.1002/cne.10693
Reese, B. E., and Keeley, P. W. (2015). Design principles and developmental
mechanisms underlying retinal mosaics. Biol. Rev. Camb. Philos. Soc. 90,
854–876. doi: 10.1111/brv.12139
Reifler, A. N., Chervenak, A. P., Dolikian, M. E., Benenati, B. A., Meyers, B. S.,
Demertzis, Z. D., et al. (2015). The rat retina has five types of
ganglion-cell photoreceptors. Exp. Eye Res. 130, 17–28. doi: 10.1016/j.exer.
2014.11.010
Robinson, G. A., and Madison, R. D. (2004). Axotomized mouse retinal ganglion
cells containing melanopsin show enhanced survival, but not enhanced
axon regrowth into a peripheral nerve graft. Vision Res. 44, 2667–2674.
doi: 10.1016/j.visres.2004.06.010
Schmidt, C., Peigneux, P., and Cajochen, C. (2012). Age-related changes in sleep
and circadian rhythms: impact on cognitive performance and underlying
neuroanatomical networks. Front. Neurol. 3:118. doi: 10.3389/fneur.2012.
00118
Schmidt, T. M., and Kofuji, P. (2009). Functional and morphological differences
among intrinsically photosensitive retinal gangion cells. J. Neurosci. 29,
476–482. doi: 10.1523/JNEUROSCI.4117-08.2009
Schmidt, T. M., and Kofuji, P. (2011). Structure and function of bistratified
intrinsically photosensitive retinal ganglion cells in the mouse. J. Comp. Neurol.
519, 1492–1504. doi: 10.1002/cne.22579
Schmidt, T. M., Taniguchi, K., and Kofuji, P. (2008). Intrinsic and extrinsic light
responses in melanopsin-expressing ganglion cells during mouse development.
J. Neurophysiol. 100, 371–384. doi: 10.1152/jn.00062.2008
Semo, M., Lupi, A. D., Peirson, A. S. N., Butler, J. N., and Foster, R. G. (2003).
Light-induced c-fos in melanopsin retinal ganglion cells of young and aged
rodless/coneless (rd/rd cl) mice. Eur. J. Neurosci. 18, 3007–3017. doi: 10.1111/
j.1460-9568.2003.03061.x
Semo, M., Muñoz Llamosas, M., Foster, R. G., and Jeffery, G. (2005). Melanopsin
(Opn4) positive cells in the cat retina are randomly distributed across the
ganglion cell layer. Vis. Neurosci. 22, 111–116. doi: 10.1017/s095252380
5001069
Sholl, D. A. (1953). Dendritic organization in the neurons of the visual and motor
cortices of the cat. J. Anat. 87, 387–406.
Spry, P. G., and Johnson, C. A. (2001). Senescent changes of the normal visual
field: an age-old problem.Optom. Vis. Sci. 78, 436–441. doi: 10.1097/00006324-
200106000-00017
Tales, A., Troscianko, T., Lush, D., Haworth, J., Wilcock, G. K., and Butler, S. R.
(2001). The pupillary light reflex in aging and Alzheimer’s disease. Aging
(Milano) 13, 473–478.
van der Meijden, W. P., Van Someren, J. L., Te Lindert, B. H. W., Bruijel, J., van
Oosterhout, F., Coppens, J. E., et al. (2016). Individual differences in sleep
timing relate to melanopsin-based phototransduction in healthy adolescents
and young adults. Sleep 39, 1305–1310. doi: 10.5665/sleep.5858
Van Someren, E. J. W. (2000). Circadian and sleep disturbances in the elderly. Exp.
Gerontol. 35, 1229–1237. doi: 10.1016/s0531-5565(00)00191-1
Viney, T. J., Balint, K., Hillier, D., Siegert, S., Boldogkoi, Z., Enquist, L. W., et al.
(2007). Local retinal circuits of melanopsin-containing ganglion cells identified
by transsynaptic viral tracing. Curr. Biol. 17, 981–988. doi: 10.1016/j.cub.2007.
04.058
Vugler, A. A., Redgrave, P., Semo,M., Lawrence, J., Greenwood, J., and Coffey, P. J.
(2007). Dopamine neurones form a discrete plexus with melanopsin cells
in normal and degenerating retina. Exp. Neurol. 205, 26–35. doi: 10.1016/j.
expneurol.2007.01.032
Vugler, A. A., Semo,M., Joseph, A., and Jeffery, G. (2008). Survival and remodeling
of melanopsin cells during retinal dystrophy. Vis. Neurosci. 25, 125–138.
doi: 10.1017/s0952523808080309
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Esquiva, Lax, Pérez-Santonja, García-Fernández and Cuenca.
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution and reproduction in other forums
is permitted, provided the original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Aging Neuroscience | www.frontiersin.org 17 April 2017 | Volume 9 | Article 79
